Asthma drug company Vectura delivers strong growth and special dividend
Drug delivery solutions company Vectura (VEC) reported strong first half growth in revenues, up 14.8% to £91.7m along with an increase in the proposed return of capital from £50m to £60m. The shares puffed up 1.9% to 81p.Product...
10 September 2019